Key result
Transcatheter aortic valve implantation (TAVI) is associated with neurologic injury, and this review summarizes the incidence, definitions, and evidence for neuroprotection and pharmacotherapy.
This review summarizes current evidence on neurologic injury, neuroprotection, and adjunctive pharmacotherapy in patients undergoing TAVI.
TAVI neurologic injury warrants clinical vigilance; review leaves open optimal neuroprotection and pharmacotherapy.
Transcatheter aortic valve implantation (TAVI) has become the preferred method of treatment for high-risk patients with severe symptomatic aortic stenosis (AS) and is a preferred alternative to surgical valve replacement for intermediate-risk patients. Stroke remains one of the most clinically devastating complications following TAVI. We review the incidence of neurologic injury related to TAVI, proposed definitions for neurologic events and current evidence for neuroprotection and adjunctive pharmacotherapy.
No takes yet. Share an insight, caveat, or question.
Lansky et al. (2018) conducted a review in Severe symptomatic aortic stenosis. Transcatheter aortic valve implantation (TAVI) was evaluated. Transcatheter aortic valve implantation (TAVI) is associated with neurologic injury, and this review summarizes the incidence, definitions, and evidence for neuroprotection and pharmacotherapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: